CJC-1295 w/o DAC 10mg + Ipamorelin 10mg Peptides
Engineered for disciplined research, this two-peptide blend is built for precision from reconstitution to final measurement.
The CJC-1295 w/o DAC + Ipamorelin lyophilized vial is a professional research format featuring growth hormone-related peptides in a stable freeze-dried matrix. This unflavored, lab-ready style supports careful handling and controlled setup. Total content is 20mg per vial to streamline standardized workflows.
- 10mg CJC-1295 w/o DAC – A growth hormone–releasing hormone (GHRH) analog widely studied for its role in supporting pulsatile growth hormone dynamics without DAC, allowing researchers to investigate shorter kinetic profiles and timing-dependent protocols.
- 10mg Ipamorelin – A selective ghrelin receptor agonist frequently examined for its growth hormone secretagogue activity, enabling controlled exploration of secretion patterns, receptor selectivity, and potential synergy when paired with a GHRH analog.
Designed for non-clinical laboratory applications, this lyophilized blend supports consistent reconstitution and repeatable aliquoting when handled with appropriate aseptic technique. The freeze-dried format helps preserve integrity during storage and transport, enabling method development, comparative assays, and protocol optimization. Its complementary peptide pairing makes it suitable for researchers evaluating pulse amplitude, timing coordination, and other parameters relevant to growth hormone signaling studies.
Use/Experience: As a non-edible, non-sterile research reagent, this vial is intended for controlled laboratory work only. Reconstitute with a suitable research solvent (not included) according to your lab’s SOPs, then proceed with the intended in vitro or ex vivo applications. No clinical, veterinary, or household use is permitted.
Safety & Trust: Peptide Scientific Labs is a USA-based source focused on consistency, transparency, and professional standards. Each lot is produced and handled in controlled environments with rigorous quality checks for identity and purity. Batches are traceable, and documentation is available to support method validation and reproducibility. For laboratory research only. Not for human consumption. Not for medical, diagnostic, or therapeutic use.
Contents: One lyophilized vial containing a total of 20mg (CJC-1295 w/o DAC 10mg + Ipamorelin 10mg).
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. For product copy, it should be described as a research peptide for endocrine signaling studies.
What is Ipamorelin typically studied for?
Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, recovery-related models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
